Public research preview
Lisa McClain, Representative disclosure: n. Otis Worldwide Corporation Common Stock (OTIS)
Disclosed a sell transaction in n. Otis Worldwide Corporation Common Stock (OTIS). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 21 Nov 2025, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 21 days
Timeline
Transaction date
31 Oct 2025
Public disclosure
21 Nov 2025
Now
Tracked today
Filing delay: 21 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 9 Jul 2026
Stock path
OTIS from pre-transaction context through latest close.
Transaction
31 Oct 2025 · 91.354 USD · Not public yet
System decision
Would not buy — The strategy's filters reject this signal. Failed filters: Buy disclosure.
- Not public yet
- Would not buy
- Observed transaction close
- 91.354
- Observed disclosure close
- 87.129
- Observed latest close
- 71.99
- Pre-disclosure move
- -4.6%
- Post-disclosure move
- -17.4%
- Market-adjusted move
- -32.3%
- Pre-disclosure peak run-up
- 0.0%
- Retrace from peak
- -4.6%
Why Copy Window is Probably too late
Supporting factors
- Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 21 Nov 2025, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%